Alvotech - *W EXP 99/99/999 (ALVOW)

CUSIP: L01800116

Q2 2026 13F Holders as of 30 Jun 2026

Share change
+24,947
SEC-reported price per share
$0.23
Number of holders
7
Value change
+$5,738
Number of buys
2

Security key

L01800116

Report period

Q2 2026

Institutions

7

Top holders

7

Ownership snapshot

Top reported holders of ALVOW - Alvotech - *W EXP 99/99/999 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Aztiq Pharma Partners S.a...
Disclosed value leader
Aztiq Pharma Partners S.a...
Comparable rows
2/15
Latest evidence
26 Jun 2026
13D/G 13F Lead comparable stake: 33% 13 rows are not safely comparable across share classes. 13D/G row: Aztiq Pharma Partners S.a r.l. Showing 1-6 of 15 holder rows.

Quick read

Aztiq Pharma Partners S.a r.l. leads the comparable SEC ownership view at 33%.

2 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Aztiq Pharma Partners S.a r.l.'s linked filing trail.
Comparable ownership Top 2
Aztiq Pharma Partners S.a r.l. 33%
Celtic Holdings SCA 28%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Aztiq Pharma Partners S.a r.l.
13D/G
33%
Reported 13D/G · 17 Dec 2025
$533,786,019
103,849,420 shares
$0 17 Dec 2025
Celtic Holdings SCA
13D/G
Celtic Holdings S.C.A.
28%
Reported 13D/G · 26 Jun 2026
$367,482,379
107,450,988 shares
$0 26 Jun 2026
VANGUARD CAPITAL MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$11,834,251
3,410,447 shares
— 31 Mar 2026
Bracebridge Capital, LLC
13F
Company
13F
—
denominator unverified
$9,279,193
2,705,304 shares
— 31 Mar 2026
MILLENNIUM MANAGEMENT LLC
13F
Company
13F
—
denominator unverified
$7,280,504
2,122,596 shares
— 31 Mar 2026
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
—
denominator unverified
$4,793,000
1,397,107 shares
— 31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
7
Shares
5,054,825
Rows available
7
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
6
Q2 2026 holders
7
Holder diff
1
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .